When delays and disruptions threaten not only product integrity but patient well-being, thorough risk assessment and mitigation are essential.

Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...

As the pharmaceutical industry ... pose potential problems for companies in the industry. This makes the need for effective security and risk management ever more important – and an intelligence ...

Sustainable pharmaceutical ... the industry is the expiration of drugs before they can be used, leading to substantial financial losses and environmental harm. AI-optimised inventory management ...

At the 35th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global conference in Vienna, Austria, the development of climate-informed infectious disease risk management ...

Industry experts ... investors with a high risk tolerance. India is actively pursuing US companies seeking to relocate manufacturing from China, aiming to capitalize on global supply chain shifts in ...

It adds: “Despite the 90-day pause on most reciprocal tariffs, the near- and longer-term outlook is dogged by tariff uncertainty, complicating investment and management decisions. The greatest risk is ...

For weeks, President Trump has made it clear that tariffs are going to be slapped on pharmaceuticals. But that is about the ...

The U.S. Food and Drug Administration's mass layoffs included senior negotiators in talks with the pharmaceutical industry ...